双开窗医师改良覆膜支架行全主动脉弓腔内修复时选择性上主动脉干支架置入对慢性A型夹层的影响
本研究回顾性分析2017至2024年42例采用双开窗医师改良覆膜支架(PMEG)行主动脉弓修复的慢性A型主动脉夹层(cTAAD)患者,比较选择性上主动脉干(SAT)支架置入对主动脉重塑、SAT演变及总体结局的影响。结果显示技术成功率100%,随访中位18.5个月,无Ia型内漏,SAT夹层完全消退率40%,积极主动脉重塑率76%,持续SAT夹层可能阻碍重塑并需额外干预。
要点
- 双开窗PMEG治疗残余cTAAD技术成功率高,SAT愈合率及主动脉重塑率良好
- 选择性SAT支架置入可减少SAT操作,可能降低卒中风险
- 持续SAT夹层可能阻碍主动脉重塑,需考虑二次SAT干预
核心结论
- 双开窗PMEG治疗残余cTAAD有效,SAT愈合率高且主动脉重塑良好。
- 持续SAT夹层可能阻碍重塑并需要额外干预。
研究设计与样本
- 回顾性分析2017至2024年42例因cTAAD行双开窗PMEG主动脉弓修复的患者。
- 比较不同SAT夹层状态(术前及术后)的主动脉治疗与重塑、SAT演变及总体结局。
主要发现
- 技术成功率为100%;30天内1例死于卒中,1例出院后死于肺炎。
- 中位随访18.5个月(IQR 38.8)期间无Ia型内漏,观察到6例Ic型内漏,其中3例再干预,3例随访CT无主动脉增长。
- SAT夹层完全消退见于12例(40%),其中9例为标准PMEG;积极主动脉重塑见于32例(76%),中位直径缩减-1%(IQR 5.5%)。
- 中期随访5例死亡,无手术相关死亡;积极重塑率在初始有/无SAT夹层者间为73% vs 83%(p=0.7),初始无SAT夹层与愈合者间为83% vs 92%(p=1),持续SAT夹层与其他患者间为61% vs 88%(p=0.07)。
关键数值与推荐
- 技术成功率100%。
- SAT夹层完全消退率40%(12/30)。
- 积极主动脉重塑率76%(32/42),中位直径缩减-1%(IQR 5.5%)。
- 持续SAT夹层者积极重塑率61% vs 其他88%(p=0.07)。
- 接受治愈性抗凝或双联抗血小板治疗者积极重塑率降低。
临床怎么用
- 双开窗PMEG行主动脉弓修复时可不常规行SAT支架置入,以减少SAT操作并可能降低卒中风险。
- 对于SAT夹层持续且主动脉增长者,可考虑二次SAT干预以促进主动脉重塑。
局限性
- 回顾性研究设计。
- 样本量较小(42例)。
- 随访时间有限(中位18.5个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the impact of selective supra-aortic trunk (SAT) stenting on aortic remodeling in patients with chronic type A aortic dissection (cTAAD). METHODS: Patients treated from 2017 to 2024 with aortic arch repair using double-fenestrated physician-modified endografts (PMEGs) for cTAAD were retrospectively analyzed. The objectives are to compare aortic treatment and remodeling, SAT evolution, and overall outcomes according to SAT dissection status (before and after), total aortic arch repair using a double-fenestrated PMEG. RESULTS: Among 42 cTAAD patients treated, 30 had SAT dissection. Thirty-five patients received a standard PMEG, while 7 underwent additional selective SAT stenting (3 LCCA, 1 brachiocephalic trunk (BT), 4 right subclavian artery (RSA), and 3 right common carotid artery (RCCA)). Technical success was 100%. At 30 days, 1 patient died from stroke, 1 from pneumonia post-discharge. During a median follow-up of 18.5 months (IQR: 38.8), no type Ia endoleaks occurred. Six type Ic endoleaks were observed; 3 patients underwent reintervention, while the remaining 3 were monitored with follow-up CT scans showing no evidence of aortic growth. Complete SAT dissection resolution occurred in 12 patients (40%), including 9 with standard PMEG. Positive aortic remodeling was seen in 32 patients (76%) with a median diameter reduction of -1% (IQR: 5.5%). Five patients died during mid-term follow-up, with no deaths related to the procedure. Positive aortic remodeling rates are 73% vs. 83% (p=0.7) between patients with and without initial SAT dissection, 83% vs 92% (p=1) between patients with initially no SAT dissection and those who healed, 61% vs 88% (p=0.07) between patients with persistent SAT dissection and the others. Patients on curative anticoagulation or dual antiplatelet therapy showed reduced positive remodeling. CONCLUSION: Double-fenestrated PMEGs are effective for treating residual cTAADs, with high SAT healing and favorable remodeling. Persistent SAT dissection may hinder remodeling and require additional intervention.Clinical ImpactAortic arch repair using fenestrated physician-modified endografts without systematic SAT stenting reduces SAT manipulation and may lower stroke risk, while promoting a high rate of SAT and aortic dissection healing. In cases where SAT dissection persists and aortic growth is reported, secondary complementary SAT intervention can be performed to enhance aortic remodeling.
引用
- Bacri C, Hireche K, Alric P, et al. Selective Supra-Aortic Trunk Stenting During Endovascular Total Aortic Arch Repair in Patients With Residual Chronic Type A Dissection Treated With Double-Fenestrated Physician-Modified Endografts. J Endovasc Ther. 2026. PMID: 41482868. doi:10.1177/15266028251410777
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。